Jump to content

Fibrinogenolysis

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by No1lakersfan (talk | contribs) at 10:06, 19 July 2019 (Removed {{Orphan}} tag from article (TW)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Fibrinogenolysis
SpecialtyHematology

Primary fibrinogenolysis is a medical condition that appears with abnormal production of fibrinogen/fibrin degradation products (FDP), degradation of coagulation factors V, VIII, IX, XI and/or degradation of the fibrin present in any pre-existing localized thrombi and hemostatic clots.[1][2]

References

  1. ^ Marder VJ, Williams WJ, Beutler E, Erslev AJ, Lichtman MA, eds. (1990). "Consumptive thrombohemorrhagic disorders". Hematology.
  2. ^ Potron G, Caen JP, Tobelem G, Soria C, eds. (1988). "Fisiopatologia delle iperfibrinolisi". Milano: Masson.


Stub icon

This article about a disease of the blood or immune system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Fibrinogenolysis&oldid=906937883"